Chapter 495: Star Group

The second phase of the human clinical trial of general cancer drugs is being held vigorously. This is a one-month clinical trial.
The one-month clinical trial has only been carried out for two days now, but preliminary results can be seen from the two-day clinical trial.
No matter what kind of cancer patients, the two-day medicine has already played a certain role in their body, and some effects can be seen from it.
Patients with advanced cancer are the most sensitive group of people, because people in this period often have more than one disease, and various complications will follow.
It is also because they are the most sensitive people, and their bodies get better, they are also the people who can feel the changes most.
Almost on the second day, they felt the changes in their bodies, which were changing for the better, and this change was extremely obvious.
When they conducted the second day of experimentation, some people posted their personal physical conditions through Weibo and Moments, and shared them with family, relatives and friends.
"Thank you very much for Star Pharmaceuticals. They gave me hope. After taking their drugs, I feel better. Looking forward to a month later, everyone will see a new me."
"After only taking medicine for one day, I feel better. Stars Pharmaceutical has given me hope of curing cancer."
"This is a comparison of the data of taking drugs and not taking drugs. I will release one data every day as a record. I look forward to it."
"In one day, I saw the hope of treating cancer. Even if it fails, I hope that everyone will not blame Xingchen Pharmaceutical too much. This is a company that strives for the hope of cancer patients."
On this day, almost everyone shared their feelings about the second phase of the human clinical trial at Star Pharma in their circle of friends.
More than 7,000 cancer patients from all over the country shared their feelings.
A hot search about "Xingchen Pharmaceutical, a general cancer treatment drug" quickly made the 24-hour hot search list.
For these 7,000 terminal cancer patients, their relatives and friends basically know their status. Seeing them say that they see the hope of survival in Star Pharmaceutical, they can't help but cheer for them.
Those who are about to participate in the third phase of human clinical trials are more concerned about the efficacy of Star Pharma’s general cancer drug. Seeing that the people in the second phase are getting better after taking the drug, they seem to see their own hope.
Not only them, more cancer patients are paying attention to the news of Xingchen Pharmaceutical's general cancer treatment.
"Xingchen Pharmaceutical 666 is indeed produced by Xingchen. It must be a boutique product. Whether it is a technological product or a pharmaceutical product, it is a first-class existence. I seem to have seen the rise of Xingchen Beverage's "Strengthening" beverage.
"It's really effective, isn't it a fraud? Now there are many companies deliberately making fake news to fool people."
"How could a subsidiary of Star Technology be falsified, and the news of these people is not the information released by Star Pharmaceuticals itself, but the information released by the people participating in the clinical trial. Many people can confirm the information of these people, and it cannot be false. of."
"That's right, how could it be fake? I now hope that Xingchen Pharmaceutical will give it a little bit more. After the second phase is completed, they will slap the people who say they are fraudulent.
"Big brothers above, I’m wrong, I’m wrong, don’t slap me in the face, I hope it’s true, because my own family has cancer, I also hope that this medicine can really treat cancer, so I There is no need to lose my loved ones."
"Support Xingchen Pharmaceutical. As long as this drug can be successfully listed, I will definitely support it."
"Support +1."
"Support +10086."
Regardless of how hot the Internet is about the general cancer treatment produced by Xingchen Pharmaceutical, Xingchen Pharmaceutical has not responded to the information on the Internet, and the second phase of human clinical trials are proceeding in an orderly manner.
Although Xingchen Pharmaceutical did not officially release any news, it did not prevent the patient from revealing his condition.
Hou Yaolin has sufficient information about this medicine, and the information released by patients is the information that has become better, which can be regarded as a disguised advertisement for Xingchen Pharmaceutical.
Since the hot topic, the topic of general cancer treatment has not been in the top ten.
Hot topics in 24 hours, topics related to stars account for half.
Netizens have taken it off this month.
Whether it's the company of Xingchen Technology, Xingchen Pharmaceutical, or Xingchen Beverage, the information given by each company is eye-catching. Even if it is not directly named with Xingchen Group, it is related to Xingchen Group.
Yes, you are right. With Liu Mingyu's permission, with more and more subsidiaries, Liu Mingyu established Xingchen Group.
The Star Group can be said to have changed from an ordinary company to a group company at the fastest speed, breaking various records.
There is no alternative. As more and more companies are acquired, setting up a group company is the best choice.
With such elites as Zhao Qingsong, he didn't need to do anything, and soon established a group company headed by Xingchen Technology.
At present, the subsidiaries are mainly divided into three, Star Technology, Star Pharmaceutical, and Star Beverage.
The valuation of every company is amazing, but the most amazing one is the valuation of Star Technology. Unfortunately, Star Technology is not listed, and many venture capital companies can only evaluate based on current data.
This kind of assessment is inaccurate, because the information they can obtain is too little, but even this ~EbookFREE.me~The valuation of Star Group has reached trillions in the venture capital industry.
Yes, I heard it right. It has reached the trillion level. Even the top investment companies at this level of financing have taken a fancy to the Star Group, because they know that as long as they catch this line, they can make a steady profit.
Xingchen Group has risen too fast. Before they can do a good job of valuation, Xingchen Group has released products that surpass the times, and they have to reassess.
Liu Mingyu rejected too many people to invest. Liu Mingyu didn't want others to get involved in the company in his hands.
For the main leaders of some people's companies, he would rather increase the rewards for them and give them more money than give them his own shares.
With more shareholders, you need to disclose some information to those shareholders.
Liu Mingyu has too much news to hide, so keeping the company firmly in his own hands is the best choice.
What's more, with a zombie conversion factory, it is a better choice to be able to produce zombies that are loyal to you.
It's not just that Xingchen Pharmaceutical is operating in an orderly manner, Xingchen Technology and Xingchen Beverage are all operating in an orderly manner. The zombie headed by Zhao Qingsong manages the company in an orderly manner.
Pick up an apocalyptic world
Pick up an apocalyptic world https://